AKRO
Akero Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
AKRO fundamentals
Akero Therapeutics (AKRO) released its earnings on Nov 7, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -0.99 (YoY +5.71%), missed estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.99
+5.71%
Report date
Nov 7, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Akero Therapeutics (AKRO) key financial stats and ratios, covering profitability, financial health, and leverage.
Akero Therapeutics (AKRO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Akero Therapeutics (AKRO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Akero Therapeutics (AKRO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Akero Therapeutics (AKRO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Akero Therapeutics (AKRO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the market's earnings forecast for Akero Therapeutics next quarter?What were the key takeaways from Akero Therapeutics’s earnings call?What does Akero Therapeutics do and what are its main business segments?What guidance did Akero Therapeutics's management provide for the next earnings period?What factors drove the changes in Akero Therapeutics's revenue and profit?Did Akero Therapeutics beat or miss consensus estimates last quarter?What were the key takeaways from Akero Therapeutics's earnings call?What is the revenue and EPS growth rate for Akero Therapeutics year over year?
